• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . The CD19+ B cell as a marker for the febrile children infected with influenza A and Omicron variant

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Oct;95(10):e29097.
doi: 10.1002/jmv.29097. The CD19[SUP]+[/SUP] B cell as a marker for the febrile children infected with influenza A and Omicron variant

Ting Shi[SUP] 1 [/SUP], Lei Xu[SUP] 2 [/SUP], Xiaohong Li[SUP] 1 [/SUP], Linlin Huang[SUP] 3 [/SUP]



Affiliations
Abstract

H3N2 and Omicron are common pathogens of respiratory infections in children. This study aimed to explore dynamic changes of lymphocyte subsets and the diagnostic value of CD19[SUP]+[/SUP] B cell in children infected with influenza A and Omicron. One hundred and sixty-five in-patients with H3N2, 175 in-patients with Omicron variant, and 50 age-matched healthy children from Children's Hospital of Soochow University were included in this study. The participants underwent 13 respiratory pathogens by DNA polymerase chain reaction (PCR), sputum culture, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) DNA PCR, routine blood, and lymphocyte subset assays within 24 h of admission. The neutrophils, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in the H3N2 and Omicron groups were significantly higher than in the control groups (p < 0.05). However, the lymphocytes and eosinophils in the H3N2 and Omicron groups were lower than the control groups (p < 0.05). The CD3[SUP]+[/SUP] T cell, CD3[SUP]+[/SUP] CD4[SUP]+[/SUP] T cell, CD3[SUP]+[/SUP] CD8[SUP]+[/SUP] T cell, CD3[SUP]-[/SUP] CD19[SUP]+[/SUP] B cell, and natural killer cell were lower in the H3N2 and Omicron groups than in the control group (p < 0.05). The CD3[SUP]-[/SUP] CD19[SUP]+[/SUP] cell in the Omicron group was higher than that in the H3N2 group but lower than that in the control group (p < 0.05). In addition, CD3[SUP]-[/SUP] CD19[SUP]+[/SUP] cell had good diagnostic value for H3N2 (area under the receiver operating characteristic curve = 0.902, p < 0.05). The children with H3N2 were more likely to have lower lymphocytes than children with Omicron. Additionally, B-cell count had good diagnostic value for H3N2.

Keywords: B cell; H3N2; Omicron; children; hemogram; inflammation.

 
Back
Top Bottom